Manufacturing CRC invites participation
04 June, 2013A new Cooperative Research Centre (CRC) for Manufacturing Industry Innovation (MIICRC) invites organisations to participate as industry partners.
Cochlear shares slump on word of weaker sales
04 June, 2013 by Dylan Bushell-EmblingCochlear Limited (ASX:COH) revealed its 2H sales have been lower as its customers awaited the now-in-process launch of its Nucleus 6 sound management product line.
FDA blocks imports of Pharmaxis asthma test
03 June, 2013 by Dylan Bushell-EmblingThe US FDA has added Pharmaxis’s Aridol to its Import Alert list, preventing the company from shipping units of the asthma test into the market.
Another pharma evaluating pSivida’s Durasert
30 May, 2013 by Dylan Bushell-EmblingpSivida (ASX:PVA) has signed an evaluation agreement with an unnamed global pharmaceutical company covering its Durasert ophthalmic insert.
AusBiotech investment summit heading for Melbourne
30 May, 2013Australia Biotech Invest 2013, the largest life science investment meeting in Australia, will this year be held on 28 and 29 October at the Melbourne Convention and Exhibition Centre.
Design your own bacteria in one step
30 May, 2013 by Lauren DavisThe production of designer bacteria for biotechnology processes used to be an inefficient one. Now, University of Adelaide researchers have developed a new method that is simple and fast.
Immuron picks new director
29 May, 2013Immuron (ASX:IMC) has named 20-year healthcare industry veteran Stephen Anastasiou as a new non-executive director.
Pharmaxis to cut 30% of jobs in restructuring
28 May, 2013 by Dylan Bushell-EmblingPharmaxis (ASX:PXS) has announced plans to cut 30% of its workforce and consolidate its manufacturing facilities, and seek partners for much of its Bronchitol commercialisation efforts.
AusFoodtech welcomes first National Food Plan
28 May, 2013AusFoodtech has welcomed the release of Australia’s first National Food Plan - a road map for Australia’s food businesses and consumers.
12 months on: REVA presents stent trial follow-up results
27 May, 2013 by Dylan Bushell-EmblingTwelve-month, follow-up data from the first eight patients enrolled in a trial of REVA Medical’s (ASX:RVA) bioresorbable coronary stent supports the safety of the product.
BioDiem secures Japanese patent for BDM-I
24 May, 2013 by Dylan Bushell-EmblingBioDiem (ASX:BDM) has picked up a Japanese patent covering antimicrobial BDM-I as a treatment for malaria and trichomoniasis.
IDT Australia announces board shake-up
24 May, 2013 by Dylan Bushell-EmblingCMO IDT Australia (ASX:IDT) has announced the pending replacement of two current board members.
Griffith Hack attracts top patent attorney
23 May, 2013IP firm Griffith Hack has welcomed the arrival of Dr Tony Davis as a Senior Associate to its growing Life Sciences and Chemical practice.
AusBiotech opposes changes to export grants scheme
23 May, 2013AusBiotech has joined several industry groups to express concern over the Export Market Development Grants (EMDG) Amendment Bill.
Local CROs team up for international trials
22 May, 2013 by Dylan Bushell-EmblingDatapharm is on the expansion path for Dai-Sys, its initiative aimed at bringing together a global network of local small to mid-size CROs for international clinical trial support services.
